Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by CLAUDEPIERRE, P.
Right arrow Articles by DOUGADOS, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by CLAUDEPIERRE, P.
Right arrow Articles by DOUGADOS, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1995 British Society for Rheumatology

research-article

PREDICTIVE FACTORS OF SEVERITY OF SPONDYLOARTHROPATHY IN NORTH AFRICA

P. CLAUDEPIERRE*, A. GUEGUEN{dagger}, A. LADJOUZE{ddagger}, N. HAJJAJ-HASSOUNI§, S. SELLAMI|, B. AMOR* and M. DOUGADOS*,

*Hâpital Cochin 75014 Paris
{dagger}INSERM Unité-88, 75013 Paris, France
{ddagger}Hôpital Ben Aknoun Algiers, Algeria
§Hôpital El Ayachi Rabat, Morocco
|Hôpital La Rabta Tunis, Tunisia

Correspondence to: Correspondence to: M. Dougados, Clinique de Rhumatologie, Hôpital Cochin, 27 rue de Faubourg Saint Jacques, 75014 Paris, France.

Both genetic and environmental factors probably influence the severity of spondyloarthropathies. Hip involvement, which may be used as a marker of disease severity, is more frequent in spondyloarthropathies developed in North Africa. The objective of this study was to determine the predisposing factors of hip involvement in spondyloarthropathy in North Africa. Patients fulfilled the Amor or European Spondyloarthropathy Study Group (ESSG) criteria of spondyloarthropathy. The study was retrospective, cross-sectional, multicentre and carried out in North Africa. The data collected were demographic data, socio-cultural factors and clinical presentation at onset. The risk of hip involvement with regard to disease duration was estimated using Kaplan—Meier's method. The predictive value of each variable with regard to time to hip involvement was evaluated using a uni- and then a multivariate Cox proportional hazard model. Five hundred and eighteen patients were included. The risk of hip involvement was estimated at 39 ± 3% after 10 yr disease duration. The factors picked up by the multivariate analysis were: diagnostic delay less than 7 yr, age at onset below 24 yr and a combination of ‘lower social class’ and ‘no refrigerator at home’. This study confirms the high prevalence of hip involvement during the course of spondyloarthropathy in North Africa and suggests a role of environmental factors in its appearance.

KEY WORDS: Spondyloarthropathy, Ankylosing spondylitis, Hip involvement, Epidemiology, Prognosis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
X. Baraliakos and J. Braun
Hip involvement in ankylosing spondylitis: what is the verdict?
Rheumatology, September 15, 2009; (2009) kep298v1.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.